Table 3 Baseline characteristics according to ABO Blood Groups

Age, years

70.7 ± 10.03

67.76 ± 9.56

69.68 ± 8.68

69.77 ± 9.08

Male, n (%)

166 (68.3)

178 (72.65)

78 (61.9)

31 (65.96)

HT, n (%)

168 (69.14)

173 (70.61)

83 (65.87)

35 (74.47)

DM, n (%)

66 (27.16)

71 (28.98)

16 (12.7)

7 (14.89)

CHF, n (%)

10 (4.12)

10 (4.08)

6 (4.76)

3 (6.38)

History of MI, n (%)

26 (10.7)

30 (12.24)

12 (9.52)

4 (8.51)

History of CAD, n (%)

45 (18.52)

53 (21.63)

21 (16.67)

8 (17.02)

History of PCI, n (%)

35 (14.4)

37 (15.1)

12 (9.52)

5 (10.64)

History of CABG, n (%)

6 (2.47)

6 (2.45)

2 (1.59)

1 (2.13)

Current smoker, n (%)

144 (59.26)

152 (62.04)

58 (46.03)

30 (63.83)

BMI, kg/m²

25.55 ± 3.76

24.25 ± 3.27

24.52 ± 2.58

25.39 ± 3.96

Symptom onset time (h)

38.92 ± 45.82

28.52 ± 43.67

33.61 ± 47.55

38.54 ± 47.27

STEMI, n (%)

165 (67.9)

174 (71.02)

69 (54.76)

29 (61.7)

Anterior MI, n (%)

122 (50.21)

131 (53.47)

59 (46.83)

23 (48.94)

Heart rate, bpm

82.93 ± 18.56

80.91 ± 15.39

80.43 ± 19.96

73.23 ± 12.54

SBP, mmHg

127.33 ± 25.55

123.88 ± 23.06

125.57 ± 23.51

128.46 ± 20.68

DBP, mmHg

71.06 ± 12.95

73.38 ± 11.75

75.32 ± 11.26

69.85 ± 9.65

KILLIP class

 KILLIP I, n (%)

128 (52.67)

129 (52.65)

63 (50)

27 (57.45)

 KILLIP II, n (%)

85 (34.98)

88 (35.92)

46 (36.51)

13 (26.66)

 KILLIP III, n (%)

17 (7)

18 (7.35)

9 (7.14)

3 (6.38)

 KILLIP IV, n (%)

13 (5.35)

10 (4.08)

8 (6.35)

4 (8.51)

β-RB in 24 h, n (%)

120 (49.38)

117 (47.76)

61 (48.41)

25 (53.19)

ACEI/ARB in 24 h, n (%)

29 (11.93)

26 (10.61)

15 (11.9)

6 (12.77)

ESR, mm/h

15.72 ± 14.52

18.17 ± 13.7

16.93 ± 13.81

13.69 ± 10

HBA1C, %

6.74 ± 1.25

6.49 ± 1.07

6.33 ± 1.3

6.19 ± 0.48

BNP (pg/ml)

760.25 (441.3, 1018.5)

641.9 (316.85, 1120)

694.22 (306.28, 994.18)

667.02 (285.95, 1010,6)

WBC, *10⁹/L

10.5 ± 4.17

10.36 ± 3.84

9.63 ± 3.93

9.36 ± 2.01

RBC, *10¹²/L

4.21 ± 0.9

4.14 ± 0.58

4.2 ± 0.48

4.02 ± 0.48

Hb, g/L

128.28 ± 22.41

127.59 ± 19.56

129.14 ± 15.23

124.33 ± 13.54

D-dimer, mg/L FEU

1.31 ± 1.21

1.37 ± 1.63

1.32 ± 0.65

1.11 ± 0.44

CK-MB, ng/ml

22 (5.95, 92.65)

28.9 (6.4, 127.03)

17.4 (1.9, 55.85)

12.1 (1.7, 43.85)

CTnI, ng/ml

7.53 (2.95, 33.7)

11.23 (6.01, 47.83)

5.62 (1.32, 39.65)

7.61 (1.32, 33.65)

LDL, mmol/L

2.58 ± 0.97

2.59 ± 0.79

2.33 ± 0.77

2.67 ± 0.95

SCR, umol/L

101.44 ± 59.81

103.9 ± 61.36

84.82 ± 21.95

76.5 ± 23.22

eGFR, ml/min/1.73 m²

71.7 ± 30.63

78.32 ± 36.61

79.41 ± 25.42

89.36 ± 34.77

SUA, umol/L

344.81 ± 101.99

338.04 ± 103.9

311.62 ± 87.29

317.36 ± 51.76

LVEDd, mm

48.31 ± 8

49.26 ± 6.33

46.91 ± 4.86

47.23 ± 5.22

LVESd, mm

35.93 ± 8.47

36.04 ± 8.09

33.61 ± 7.27

36.08 ± 8.22

LVEF (%)

52.09 ± 10.91

55.16 ± 11.6

58.43 ± 10.62

55.46 ± 11.36

GRACE RS

182.7 ± 42.85

174.03 ± 44.38

167.36 ± 36.23

169.08 ± 32.71

Primary PCI treatment, n (%)

161 (66.26)

166 (67.76)

80 (63.49)

30 (63.83)

Heart rupture, n (%)

30 (12.35)

18 (7.35)

10 (7.94)

3 (6.38)

Mortality, n (%)

33 (13.58)

25 (10.2)

12 (9.52)

5 (10.64)